Growth Metrics

GoodRx Holdings (GDRX) Income towards Parent Company (2019 - 2025)

Historic Income towards Parent Company for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • GoodRx Holdings' Income towards Parent Company fell 7177.81% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.8 million, marking a year-over-year increase of 29578.27%. This contributed to the annual value of $16.4 million for FY2024, which is 28482.18% up from last year.
  • As of Q3 2025, GoodRx Holdings' Income towards Parent Company stood at $1.1 million, which was down 7177.81% from $12.8 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Income towards Parent Company high stood at $58.8 million for Q2 2023, and its period low was -$41.7 million during Q3 2022.
  • In the last 5 years, GoodRx Holdings' Income towards Parent Company had a median value of $1.1 million in 2025 and averaged -$1.3 million.
  • Over the last 5 years, GoodRx Holdings' Income towards Parent Company had its largest YoY gain of 425448.76% in 2023, and its largest YoY loss of 121181.54% in 2023.
  • GoodRx Holdings' Income towards Parent Company (Quarter) stood at -$39.9 million in 2021, then skyrocketed by 95.06% to -$2.0 million in 2022, then plummeted by 1211.82% to -$25.9 million in 2023, then surged by 126.05% to $6.7 million in 2024, then tumbled by 83.4% to $1.1 million in 2025.
  • Its Income towards Parent Company was $1.1 million in Q3 2025, compared to $12.8 million in Q2 2025 and $11.1 million in Q1 2025.